Introduction
The spliceosomal U snRNAs U 1, U2, U4, U5 and U6 form a functionally related and highly conserved family in eukaryotes. In contrast, the promoters of their genes are quite divergent between species and, in addition, U snRNA promoters in most species display unusual features (Dahlberg and Lund, 1988; Simmen et al., 1992a; Bernuds et al., 1992) . Vertebrate U snRNA promoters contain a distal sequence element (DSE) located -250 bp upstream of the initiation site which functions like an enhancer, and a proximal region, including an essential proximal sequence element (PSE) located -50 bp from the initiation site. The PSE functions in start site positioning and is required for accurate 3' end formation. A promoter with only these Oxford University Press elements, like those of the U 1 or U2 genes, is transcribed by RNA polymerase II (pol II). The U6 gene, which is transcribed by RNA polymerase Ill (pol IH), has in addition to the DSE and PSE an essential TATA box located between the PSE and the start site (reviewed by Dahlberg and Lund, 1988; Parry et al., 1989; Bernues et al., 1992) .
The finding of an essential TATA element in the U6 and related pol HI promoters was of interest since the TATA box had, until then, been considered the main determinant of pol II transcription in a major class of pol II promoters. The first stable interaction between a transcription factor and such a basal pol II promoter is the binding of transcription factor TFIID to the TATA box. All the subsequent interactions required to assemble a functional transcription complex depend on this initial step Roeder, 1991 and references therein) . TBP, the protein directly responsible for binding the TATA box, has been cloned from several organisms. At least in vertebrates and insects TBP has been found to be only one component of one or more multiprotein TFIID complexes (Cavallini et al., 1989; Hahn et al., 1989; Horikoshi et al., 1989; Schmidt et al., 1989; Fikes et al., 1990; Gasch et al., 1990; Hoey et al., 1990; Hoffmann et al., 1990a,b; Kao et al., 1990; Muhich et al., 1990 ; Peterson et al., 1990; Dynlacht et al., 1991; Pugh and Tjian, 1991; Timmers and Sharp, 1991) . In this paper we will follow the nomenclature suggested by Dynlacht et al. (1991) who called the cloned protein TBP (for TATA-binding protein) and referred to the complex(es) involved in pol II transcription as TFIID. The work of Timmers and Sharp (1991) suggested that two such complexes exist, called B-TFIID and D-TFIID, which differ in their composition and chromatographic behaviour.
In vivo experiments in which promoter sequences were swapped between vertebrate U6 and U2 genes showed that insertion of a U6 TATA box into a U2 promoter conferred pol HI specificity, whereas removal of the U6 TATA box abolished pol III transcription, but allowed pol II transcription from the mutant U6 promoter (Mattaj et al., 1988; Lobo and Hernandez, 1989) . More recently, Lescure et al. (1991) have shown that insertion of a TATA box into a Xenopus Ul promoter conferred pol Im specificity, reinforcing the correlation between the presence of a TATA box and the use of pol HI for U snRNA genes. This apparent paradox was underlined by the demonstration that transcription of a human U6 gene by pol Im in vitro required TBP (Lobo et al., 1991; Simmen et al., 1991) . The simplest hypothesis to explain polymerase choice in U snRNA promoters at that time was that a PSE-binding factor on its own would select pol II without the involvement of TBP whereas the PSE factor in conjunction with a TATA-bound TBP (Margottin et al., 1991; Huet and Sentenac, 1992; Kassavetis et al., 1992; Lobo et al., 1992; Simmen et al., 1992b; Taggart et al., 1992; . TBP is also a component of SLI, which is necessary for transcription from pol I promoters (Comai et al., 1992) . In addition, TBP complexes have been shown to function in the pol II transcription of two similar (artificial) TATA-less promoters (Smale et al., 1990; Tjian, 1990, 1991; Zhou et al., 1992 . The longer extension product was five nucleotides longer, and comigrated with a product derived from an adenovirus major late (AdML) promoter G-less cassette fusion whose transcripts are extended by five bases at the 5' end by comparison with those from the Ul construct. This is the length expected for read-through products arising from non-specific transcription initiated upstream of the promoter after their cleavage by RNase T 1. Thus, the Ul in vitro transcription obtained was not only more efficient but also more accurate than that seen by Gunderson et al. (1990) (Nakajima et al., 1988; Simmen et al., 1991; Figure ID , lane 1). Simmen et al. (1991) (Segall et al., 1980) A, B, C and D fractions and tested the fractions for their ability to restore Ul transcription to a heat-treated extract.
The AdML promoter was used as a control. As expected (Nakajima et al., 1988 ) the PC D fraction, which contains D-TFIID, was sufficient to restore transcription to a heattreated extract, while the A, B and C fractions were inactive ( Figure 1C , lanes 9-12). When the same fractions were tested with the human Ul template, the A and B fractions had no effect ( Figure 1C, lanes 1 and 2) (Simmen et al., 1991) Initially, the PC C fraction was chromatographed over heparin-Sepharose.
Step elution at 100 (FT fraction), 250 and 500 mM KCI was carried out, and the fractions will be referred to as Hep100, Hep250 and Hep5OG. They were tested for their ability to restore transcription in heat-treated HeLa nuclear extract in the presence of hTBP. Virtually all the activity was found in Hep500 ( Figure ID, lanes 1-5) . The transcription observed was sensitive to 0.2 atg/ml ceamanitin (lanes 6-10).
We next turned our attention to U6. In our experiments fractionation of HeLa cell nuclear extracts active in U6 Fig. 1 . Heat-labile components required for human Ul transcription in vitro. (A) In vitro transcription of a human U1 promoter G-less cassette template (hUlG-) using HeLa cell nuclear extract. In vitro transcription of hUIG-(lanes 1-4) was assayed without (lanes 1 and 3) or with the addition of 2.5 ng of recombinant full-length hTBP (lanes 2 and 4). The assays in lanes 3 and 4 were done in the presence of 0.2 Lg/Iml of camanitin. An hUl PSE mutant template (containing a CC-TT double point mutation previously shown to render it inactive both in vivo and in vitro; Gunderson et al., 1990) (Figure 2A , lanes 1 and 2, and data not shown). This was not due to the loss of enhancer effects, since the same phenomenon was observed using templates from which the DSE had been deleted (data not shown). In the presence of recombinant hTBP, lack of fractions A, B or C caused a significant drop in transcription while lack of fraction D had no effect ( Figure 2A , lanes 3-6).
To compare the behaviour of the factor in fraction C required for U6 transcription with that of the Ul factor described above, we examined the ability of the heparin-Sepharose fractions used in Figure 1D Figure 2B , the bulk of the factor(s) required for U6 transcription fractionated into Hep500 (lanes 3-8), as did the heat-labile Ul transcription factor ( Figure ID) . Note, however, that HeplO0 supported a low level of U6 ( Figure 2B , lanes 3 and 4), but not U1 ( Figure 1D , lane 3) transcription.
In order to determine whether the factor in the C fraction behaved like TFLIC, the pol III transcription factor required for tRNA and 5S rRNA gene transcription, we analysed the heparin-Sepharose fractions for their content of TFIHC. This was achieved by examining their ability to complement the PC B fraction to allow tRNA transcription ( Figure 2C ). TFHIC did not bind significantly to the heparin-Sepharose column, but eluted into Hepl00 (lanes 3-10). This suggests that TFIIC is not required for U6 transcription, consistent with the data of Waldschmidt et al. (1991) who reached the same conclusion on the basis of experiments in which TFIIC activity was inhibited by specific oligonucleotide binding. The same authors (Waldschmidt et al., 1991; Simmen et al., 1992a) provided evidence that a component of the PC C fraction essential for U6 transcription was PBP (PSEbinding protein). PBP can be detected in the C fraction by electrophoretic mobility shift assay using labelled promoter DNA fragments including the mouse U6 PSE sequence as probe [Waldschmidt et al., 1991;  Figure 3A , lane 1 (the band marked with an asterisk is not PSE-dependent and the rapidly migrating complex is not reproducibly observed, see below)]. Upon fractionation, PBP was mostly present in Hep500 ( Figure 3A , lanes 2-4). The specificity of the complex for intact PSE sequences was demonstrated by competition with unlabelled wild-type and mutant PSE oligonucleotides ( Figure 3B , lanes 2-8). When the same oligonucleotides were added to reconstituted Ul transcription reactions, it was found that the wild-type mouse U6 PSE oligonucleotides were efficient competitors of specific Ul transcription ( Figure 3C , lanes 1-4) while mutant U6 PSE oligonucleotides were not (lanes 5 and 6) suggesting that PBP is required for Ul as well as for U6 transcription.
Additional evidence for the involvement of PBP in Ul transcription came from an examination of the heat sensitivity of PBP binding to the PSE in vitro. The PC C fraction was subjected to mild heat treatment (47°C for 15 min). When 3576 the heat-treated fraction was used in an electrophoretic mobility shift assay, the amount of detectable PBP activity was reduced by a factor of 10 ( Figure 3B , lanes 11 and 12) while the non-specific binding activity was unaffected. Other experiments (data not shown) confirmed that the activity of the PBP fraction in both Ul and U6 transcription and in PSE binding exhibited similar heat sensitivity. Together with the results described above this implicates PBP in the transcription of human Ul and U6 genes and, furthermore, suggests that PBP is one essential heat-labile factor present in the PC C fraction. Further fractionation will, however, be required to establish whether the U1 and U6 requirements for this fraction are completely identical and confined to PBP.
The requirements for TBP of Ul and U6 are not identical Having established that Ul and U6 transcription had similar PBP requirements, we next examined their TBP requirements. In a first experiment, we compared the ability of various forms of recombinant TBP, in combination with the PBP-containing HepSOO fraction, to restore Ul or U6 transcription to heat-treated nuclear extract. Full-length recombinant human and yeast TBP and the conserved core region (amino acids 155 -335) of human TBP were tested. The three proteins restored AdML transcription to similar levels when tested in the same extracts (data not shown). Neither the Hep500 nor any of the TBP forms could support high levels of Ul or U6 transcription alone, although as before ( Figure IC , lane 3) the PBP fraction did restore some Ul transcription ( Figure 4A and B, lanes 1-5). In combination with the PBP fraction, however, all three forms of TBP allowed efficient U6 transcription, although the core fragment also produced a high background smear of transcription ( Figure 4A , lanes 6-8). The result with the U1 promoter was different. Here both forms of human TBP had similar activity ( Figure 4B , lanes 6 and 7). Yeast TBP, however, did not increase Ul transcription above the level seen with Hep500 alone ( Figure 4B , lanes 2 and 8). Thus, transcription of the Ul and U6 genes have different TBP requirements. On their own, all forms of TBP increase readthrough transcription to some extent. This increase is suppressed in the presence of specific transcription ( Figure 4B , lanes 6 and 7) suggesting that specific and nonspecific transcription are competitive processes. containing the mouse U6 PSE (see Materials and methods for details). The PBP-PSE-specific complex is indicated by an arrowhead; a non-specific complex is indicated by an asterisk. (B) On the left panel, the specific PBP complex obtained with the heparin-Sepharose 500 mM KCl eluate (using 1 Al of Hep500 per lane, lanes 2-8) was competed with increasing amounts (10, 50 and 100 ng) of oligonucleotides containing either a wildtype (lanes 3-5) or a mutated (lanes 6-8) mouse U6 PSE. Lanes 1 and 2 show the mobility of the free probe and of the uncompeted complex, respectively. On the right panel, the effect of heat-treatment (470C, 15 min) on the formation of the PBP-specific complex was determined. Lanes 9-11 are controls containing probe alone, and probe plus 1 Al of either 500 mM KCl heparin-Sepharose fraction or untreated PC C fraction, respectively. Lane 12 contains PC C fraction heat-treated at 470C for 15 min prior to the assay. F: free probe; C: PBP-specific complex; *: a nonspecific complex. (C) Human Ul transcription is inhibited in vitro by an oligonucleotide containing the mouse U6 PSE. Aliquots (3 Al) the PC C fraction were incubated with different amounts of the appropriate oligonucleotide for 10 min on ice and then 9 1zl of heat-treated (470C, 15 min) HeLa nuclear extract, 2.5 ng of purified hTBP, DNA template, salts and nucleotides were immediately added. In lane 1 the preincubation was with buffer. Lanes 2, 3 and 4 were preincubated with 10, 25 ."-4xm am is U.
Im identify fractions necessary for Ul transcription, we adopted a chromatographic scheme that allows more efficient separation of the various identified TBP complexes than does the fractionation procedure used above (see e.g. Taggart et al., 1992) . This involves step elution from PC with 0. 1, 0.3, 0.5, 0.7 and 1.0 M KCl.
The fractions obtained were first tested with an AdML template. In the presence of the 0.1 and 0.5 M fractions, weak transcription was observed ( Figure SA, lane 1) . The 0.3 M fraction was not required for AdML transcription, and, in fact, had an inhibitory effect (lane 2). Both the 0.1 and 0.5 M fractions were essential (lanes 4 and 5) . The D-TFIID-containing 0.7 M fraction stimulated transcription 5-fold (lane 3) but was not absolutely required. The 1.0 M fraction behaved similarly to the 0.7 M fraction (data not shown).
In the case of human U1 transcription, combination of the 0.1 and 0.5 M fractions was again sufficient for transcription ( Figure SA, lane 6) , and both these fractions were also essential (lanes 9 and 10). However, the effects of the 0.3 and 0.7 M fractions were different than with the AdML promoter. The 0.7 M fraction had a reproducible inhibitory effect (lane 8 and data not shown) while the 0.3 M fraction was stimulatory (lane 7). The 1.0 M fraction had a modest inhibitory effect on human Ul transcription, similar to that of the 0.7 M fraction, when combined with the 0.1 and 0.5 M fractions (data not shown).
To determine which of the two essential fractions contained the TBP necessary for human U1 transcription, depletion experiments were carried out with a polyclonal antiserum raised against human TBP (Simmen et al., 1992b ). The 0.1 and 0.5 M fractions were either mock-depleted (designated 0) or TBP-depleted (-) and their transcription activity tested. Removal of TBP from the fractions was confirmed by Western blot analysis (data not shown). Depletion of the 0.5 M fraction severely reduced transcription ( Figure SB , lanes 1, 2, 3, 6 and 7) while depletion of the 0.1 M fraction had no effect (lanes 1 and 4-7) . Thus, the 0.5 M fraction contained the TBP required for Ul transcription.
Much of the TBP in the 0.5 M fraction has been reported to be in complexes that may be functionally different from the active D-TFIID in the 0.7 M fraction, although their composition is related to that of D-TFIID (Taggart et al., 1992) . To examine further the state of the TBP required for Ul transcription, we fractionated the 0.5 M PC fraction over heparin-Sepharose, to produce fractions analogous to those obtained previously from the PC C fraction (Figures 1-3 ). These fractions were tested for their ability to reconstitute U1 transcription together with the 0.1 M PC fraction and the TBP-depleted 0.5 M fraction. To distinguish these fractions from those derived from the C fraction, we denote them HepGOO', Hep 250' and Hep5OO'.
The activity recovered was mainly in HepSOO' ( Figure 5C , lanes 1-5), although this fraction only contained a minority of the total TBP from the 0.5 M fraction, as judged by Western blotting ( Figure SD, lanes 1-5) . Combination of Hep500' with either Hep250' or HeplOO' failed to stimulate transcription further ( Figure 5C, lanes 5-7) . The decreased transcription level in lanes 6 and 7 was due to the fact that they contained half as much HepSOO' as did lane 5. We conclude that the TBP (or TBP complex) required for Ul transcription is a minor fraction of the total TBP present in the 0.5 M fraction and that it cofractionates with PBP on heparin -Sepharose. U 1 transcription activity was reproducibly lost when the 0.5 M fraction was passed over heparin-Sepharose (e.g. Figure SC , lanes 2 and 5). In contrast, the HepSOO fraction had a higher specific activity than the C fraction when tested, in combination with hTBP and the A and B PC fractions, in U6 transcription assays (J.Lewis, unpublished data). This suggests that PBP is probably stable to heparin-Sepharose fractionation but that another component required for Ul transcription, perhaps the TBP complex, is partially inactivated at this stage.
The similar heat sensitivity of TBP and PBP (see above) suggested that the two factors might be present as a single complex. We have, however, found no direct evidence to support this hypothesis. In fact, TBP depletion from these fractions or from the PC C fraction had no significant effect on the quantity of PBP detectable by electrophoretic mobility shift assay and addition of recombinant hTBP to heat-treated C fraction did not restore PBP complex formation (data not shown).
It remained possible that the TBP (complex) required for U 1 transcription was identical to one of the complexes previously described as being competent to support pol II transcription (D-TFIID and B-TFIID/TFLIIB, Timmers and Sharp, 1991; Simmen et al., 1992b) Figure 6B , lane 2), demonstrating that factors other than TBP in the B fraction were required for U6 transcription. The PC B fraction, and the DEAE-Sephadex (DS 0.135) and Mono Q fractions derived from it (Simmen et al., 1992b) , were shown to contain similar amounts of TFHB activity by their ability to complement the TBP-depleted C fraction to reconstitute tRNA transcription ( Figure 6B, lanes  11-14) . These fractions were then tested for U6 activity. In combination with recombinant human TBP the TFHB fractions were able to generate U6 transcription in the reconstitution experiment ( Figure 6B , lanes 2-5) suggesting that TFLIB is required for U6 transcription, consistent with previous work (Waldschmidt et al., 1991) . The Mono Q fraction appeared significantly less active in U6 than in tRNA transcription when compared with DS 0.135, although reconstitution of U6 transcription with the Mono Q fraction was readily detectable after longer autoradiographic exposure (data not shown). Attempts to reconstitute U6 transcription activity by the addition of other Mono Q fractions have thus far not been successful (our unpublished data).
We wished to determine whether D-TFIID could substitute for recombinant TBP in U6 transcription. Although the D-TFIID fraction was highly active when tested with the AdML promoter ( Figure 6A , lane 3) it was unable, either alone or in combination with the TFBIB fractions, to reconstitute U6 transcription ( Figure 6B, lanes 6-10) . This was not attributable to a non-specific inhibitory effect of the D-TFIID fraction on pol HI transcription, since it did not affect tRNA transcription ( Figure 6B , lanes 11-14 and data not shown).
Ul, but not U6, requires TFIIB The discovery that a subunit of TFIIIB is highly related to the pol II basal factor TFIIB (Buratowski and Zhou, 1992 genes. Given the similarity of promoter structure exhibited by members of the vertebrate U snRNA gene family transcribed by pol II (e.g. Ul) and by pol III (e.g. U6), it was of particular interest to search for similarities and differences in their factor requirements. Both classes of promoter appeared to utilize the same PBP, but differences were seen in the requirements of Ul and U6 for TBP and for TFIIB and TFIIIB. While previous studies have emphasized similarities in factor utilization by the two promoter classes, these are the first reported differences which help to explain the basis of alternative polymerase choice by the two promoters.
PSE-binding protein and U snRNA transcription
A fraction derived from HeLa cell extract required for the transcription of a mouse U6 snRNA gene was characterized by Waldschmidt et al. (1991) . This fraction contained a factor, named PBP, which specifically bound to the PSE of the mouse gene. Subsequently, a correlation between the ability of various U6 PSE sequences to activate transcription in vitro and in vivo and to bind PBP in vitro was established (Simmen et al., 1992a) , supporting the hypothesis that PBP was involved in U6 transcription. Parallel studies of transcription of another human snRNA gene, that encoding 7SK RNA, led to the identification of a factor, named PSE transcription factor (PTF), whose properties suggest that it is likely to be identical to PBP (Murphy et al., 1992) . PTF, like PBP, was shown to bind to the PSEs of a number of mammalian U snRNA genes in vitro, including those with diverged sequences like that present in the human Ul gene. Like PBP, PTF showed highest affmity for the mouse U6 PSE (Murphy et al., 1992; Simmen et al., 1992a Reddy, 1988) . U6 is the first pol III gene whose transcription has been shown to require this factor. It is, on the other hand, very plausible that pol II transcription of U1 would, in common with many other pol II genes (see Roeder, 1991 , for a review), require TFIIA.
A second component of this fraction which may be required for both U1 and U6 transcription is Oct 1. As mentioned above, Oct 1 potentiates PBP binding to PSEcontaining oligonucleotides in vitro, and the ability of PBP to stimulate 7SK transcription (Murphy et al., 1992) . Although neither U1 nor U6 transcription in fractionated extract is dependent upon the Oct-I-binding sites present in the DSEs of the two promoters (our unpublished data) it may be that Oct-I is nevertheless required for their transcription. When the 0.1 M PC fraction was subjected to further chromatographic steps, U6 transcription activity was found to co-fractionate with both TFIIA and Oct 1 (J.Lewis, unpublished data).
In contrast, a third component of the 0.1 M KCl fraction implicated in Ul transcription, PSE-1/Ku Knuth et al., 1990) , did not cofractionate with U6 transcription activity. In fact, the most highly purified components derived from the A, B and C fractions that had U6 transcription activity contained little or no PSE-1/Ku as determined by Western blotting (S.Gunderson, J.Lewis, K.Simmen and R.Waldschmidt, unpublished data). This, coupled with the strong evidence implicating PBP in snRNA gene transcription (Waldschmidt et al., 1991; Murphy et al., 1992; Simmen et al., 1992a ; this paper), makes it unlikely that PSE-1/Ku is an essential, generally required, PSEbinding factor. Our results, however, do not rule out the possibility that PSE-1/Ku may play a role in U1 transcription since the most purified fractions sufficient for Ul transcription still contain considerable amounts of PSE-1/Ku (unpublished data). Indeed, a general role for PSE-1/Ku in pol II transcription has recently been proposed (Dvir et al., 1992; Gottlieb and Jackson, 1993) .
Differential TBP requirements for Ul and U6 transcription
The data presented here, together with previous studies (Lobo et al., 1991; Simmen et al., 1991; Waldschmidt et al., 1991) [see Rigby (1993) for a review and references] and cannot be functionally substituted for by them (Figure 6 ). While TBP complexes have previously been observed in the same PC fraction as the Ul activity (Taggart et al., 1992) , our further fractionation on heparin-Sepharose ( Figure 5 ) led to the conclusion that only a minority of the TBP in the 0.5 M PC fraction is active in U1 transcription (although we cannot rule out the possibility that the heparin-Sepharose chromatography resulted in a partial disruption of TBP complexes in this fraction). The low abundance has thus far hampered further characterization of the state of the TBP in the active fraction, but larger scale experiments should resolve this point. The nature of this complex is of particular interest since human Ul is the first genuine TATA-less pol II promoter whose transcription factor requirements have been examined, previous experiments with TATA-less promoters all having been carried out with artificial constructs that, unlike Ul, require D-TFIID-containing fractions for their transcription (Smale et al., 1990; Tjian, 1990, 1991; Zhou et al., 1992 the U1 or U6 promoter has no effect on transcription efficiency, and thus basal promoter activity was measured.) The second line of evidence is that U6 and Ul transcription in vitro require different TBP-containing fractions.
U6 transcription requires TFIIIB-containing fractions (Waldschmidt et al., 1991;  Figure 6B ), as well as, apparently, a second component of the PC B fraction not required for tRNA transcription. This can be deduced from the differential loss of U6 and tRNA transcriptional activity upon Mono Q fractionation of TFIIB activity ( Figure 6 ). TFIIB is a TBP-containing complex (Huet and Sentenac, 1992 ; Kassavetis et al., 1992; Lobo et al., 1992; Simmen et al., 1992; Taggart et al., 1992; . However, TFIHB fractions alone are insufficient to fulfil the TBP requirement of the U6 gene. After fractionation, TBP addition was essential to obtain efficient transcription, suggesting that fractionation had disrupted or destroyed an essential component of the U6 transcription machinery which could be substituted by recombinant TBP. This alone would suggest that the U6 TBP requirement is different from that of other previously studied genes, since other promoters that show such behaviour have not been described. Together with the TFIB requirement, it furthermore suggests that U6 transcription involves more than one TBP molecule, and possibly more than a single TBP complex. It has previously been reported that D-TFIID-containing fractions can substitute for TBP in restoring U6 transcription in fractionated systems, albeit with very low efficiency (Waldschmidt et al., 1991; Lobo et al., 1992) . However, highly purified D-TFIID does not have this ability ( Figure 6B ). We would suggest that the previous results may be explained by the presence of small quantities of free TBP in the crude D-TFIID fractions, and conclude that either free TBP or an unstable TBP complex is involved in U6 transcription.
Polymerase choice Previous work has suggested that U6 transcription requires TFIIA (Waldschmidt and Seifart, 1992) . The differential requirements of Ul and U6 transcription for TFIIB and TFLIIB described here are the first examples of dissimilar requirements for basal factors in the transcription of these genes. We propose the following model for the differential ability of the promoters to attract TBP complexes. The only DNA sequence absolutely required for basal vertebrate pol II U snRNA gene transcription is the PSE (reviewed by Dahlberg and Lund, 1988; Parry et al., 1989; Bernues et al., 1992) . PBP bound to the PSE, perhaps in combination with TFIIA and/or Oct 1 or other members of the Oct family (Murphy et al., 1992) would bind to the form of TBP identified here as being necessary for U1 transcription, possibly via a tethering factor or TFII-I (see Tjian, 1990, 1991; Roeder, 1991) . This complex would then attract TFIIB and, from that point, pol II transcription complex assembly could follow its conventional route (reviewed by Roeder, 1991) . In contrast, we would propose that PBP and either free TBP or an unstable TBP complex would interact with the PSE and TATA sequences of the U6 promoter respectively. The combination of these factors, again probably in conjunction with Oct 1 and TFIIA, would act as assembly factors for the pol III transcription factor, TFJIB. These factors would thus be functionally analogous to TFIIIC in tRNA, or to TFIHA plus TFIIIC in 5S rRNA transcription (Kassavetis et al., 1990) . In this model, the ability of the two classes of U snRNA promoter to select different polymerases would be explicable by their interaction with alternative TBP complexes, just as has been previously proposed for other pol l, II and HI promoters (see Rigby, 1993 , for review) whose structures are much more obviously different from one another than are those of the human U1 and U6 genes.
Materials and methods
Nuclear extract preparation and fractionation HeLa cell nuclear extracts were prepared as described by Dignam et al. (1983) except that a reduced volume of buffer C was used in the extraction step. The amount of buffer C used corresponded to one-third of the packed cell volume. For pol HI transcription studies the extracts were fractionated over PC (Whatman P11) into four fractions according to Segall et al. (1980) . The protein concentration of the fractions used here were PC A (100 mM flowthrough, 4 mg/ml protein), PC B (at 0.35 M KCl, 2 mg/ml protein), PC C (at 0.6 M KC1, 0.9 mg/ml protein) and PC D (at 1 M KCI, 0.7 mg/ml protein). Similar concentrations were obtained from repeated fractionations.
PC C fraction (containing PBP activity) was further fractionated over heparin-Sepharose and fractions were collected at 100, 250 and 500 mM KC1. The protein concentration of the heparin-Sepharose fractions used were 0.25, 0.4 and 0.9 mg/ml respectively. PC B fraction was further fractionated over DEAE-Sephadex and subsequently over Mono Q as recently described (Simmen et al., 1992b) . All fractions were extensively dialysed against buffer D (100 mM KCl, 0.2 mM EDTA, 20% glycerol, 0.5 mM DTT, 20 mM HEPES, pH 7.9, 0.1 mM PMSF) and stored at -800C until use.
For pol II transcription studies nuclear extracts were fractionated over PC (Whatman P11) essentially as described by Reinberg and Roeder (1987) . (1990) . Pol mII transcription conditions were as described by Simmen et al. (1991) except that PC A, B and C fractions prepared as described above were used.
TBP-immunodepletion of PC fractions and immunoblot analysis
The fractions, as described in the text, were TBP-immunodepleted with a rabbit polyclonal anti-hTBP antibody prepared and used as described in Simmen et al. (1992b) . Mock-depletion was performed in exactly the same way but using preimmune serum. The presence of TBP in fractions was assayed using 100 A1 of the indicated fractions with the ECL system (Amersham) for Western blotting (Simmen et al., 1992b) .
Gel retardation assays
Gel retardation assays were performed usin' conditions modified from those described by Fried and Crothers (1981) . The protein fractions were preincubated with 600 ng poly[d(IC)] in 1 x binding buffer (5% Ficoll, 100 mM KCI, 20 mM Tris-HC1, pH 8, 1 mM DTT) at 30°C for 30 min.
Then 20 000 c.p.m. of a kinased probe was added and incubation continued for a further 30 min. DNA-protein complexes were then resolved on a 6% non-denaturing polyacrylamide gel in 0.5 x TBE. The probe contained the mouse U6 gene promoter sequences from -80 to -4 (Ohshima et al., 1981) and was excised from a PCR-generated derivative of the mouse U6 column (Diagen) equilibrated in lysis buffer. After loading, the resin was extensively washed, first with lysis buffer followed by D buffer and finally eluted with 3-5 vol of D buffer containing 100 mM imidazole. Active fractions were pooled, aliquoted, frozen in liquid N2 and stored at -80°C. Recombinant yeast TBP was expressed in E. coli and purified as described in Burton et al. (1991) .
TFIIB
Recombinant TFIIB was expressed in E. coli and purified as described (Ha et al., 1991) . The 2G8 monoclonal anti-TFIIB antibody (V.Moncollin, unpublished data) was purified as follows. 1 ml ascites fluid was diluted 1:10 with phosphate-buffered saline (PBS) and passed over a protein A-Sepharose column. The column was washed with 100 ml of PBS then eluted with 0.05 M sodium acetate, pH 4. Fractions (1.5 ml) were neutralized with 750 1l 1 M Tris-HCI pH 8.0 and dialysed against buffer C (see D- TFIID purification section) before use.
Endogenous D-TFIID purification D-TFIID was purified from HeLa whole cell extract by sequential chromatography on Heparin-Ultrogel and DEAE-5PW (Moncollin et al., 1986) followed by hydrophobic and DNA-affinity chromatography as described below. The DEAE 0.25 M KCI active fractions were pooled, adjusted to 0.9 M (NH4)2SO4 with solid ammonium sulphate and loaded onto a TSK-Phenyl-SPW column (2.15 cm x 15 cm, flow-rate 2.5 nl/min) equilibrated with buffer A [59 mM Tris-HCl, pH 7.9, 50 mM KCI, 0.5 mM DTT, 0.1 mM EDTA, 8.7% glycerol and 0.9 M (NH4)2 S04]. After washing with buffer A, the proteins were eluted with a 250 ml linear gradient from 0.9 to 0 M (NH4)2SO4 in buffer A. The active fractions, eluted at 0.2 M (NH4)2SO4, were pooled (50 ml) and dialysed against buffer B (50 mM Tris-HCl, pH 7.9, 50 mM KC1, 17.5% glycerol, 5 mM MgCl2, 0.1 % Nonidet P-40, 1 mM DTT). This fraction was then incubated at 4°C for 15 min with 100 yg/ml of poly(dG-dC) and 5 mM MgCl2. 2 ml of TATA-containing DNA affinity resin (Moncollin et al., 1990) were added and the incubation continued for 15 min. The resin was then packed and washed with 10 column volumes ofbuffer B. Proteins were eluted in fractions of 1 ml with buffer B containing increasing concentrations of KCI (in irements of 0.1 M). The D-TFJID-containing frcions (eluted at 0.4-0.5 M KCI) were dialysed against buffer C (50 mM Tris-HCI, pH 7.9, 50 mM KCI, 17.5% glycerol, 0.1 mM EDTA, 0.5 mM DTT) and stored at -800C.
